GSK Investigational Site is a clinical research site located in Grapevine, Texas, United States 76051.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 3 clinical trials.
Therapeutic areas: Lung Cancer, Non-Small Cell, Respiratory Syncytial Virus Infections, Diabetes Mellitus, Type 2.
Sponsors: GlaxoSmithKline.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 3 clinical trials on record. Their work covers Lung Cancer, Non-Small Cell, Respiratory Syncytial Virus Infections, Diabetes Mellitus, Type 2.
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.